U.S., Sept. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07796737) titled 'Efficacy of Progesterone and Low Molecular Weight Heparin in Recurrent Miscarriages' on April 24.
Brief Summary: The objective of the trial is to assess whether the combination of enoxaparine (LMWH) with progesterone increases the live birth rate compared to standard of care (no active treatment) in women with unexplained recurrent pregnancy loss.
Study Start Date: Dec. 01, 2026
Study Type: INTERVENTIONAL
Condition:
Pregnancy Loss
Pregnancy Loss, Early
Intervention:
DRUG: Vaginal micronized progesterone
Vaginal micronized progesterone 800 mg daily administered in two divided doses .
DRUG: Enoxaparin (LMWH)
Administered subc...